Skip to Main Content

WASHINGTON — Like many Americans, Cindy Biter thinks drug costs are a problem. She’s not sure what to do about them, though — and, as a Republican, she’s skeptical about the federal government intervening in the free market.

But when she hears the pharmaceutical industry’s argument that government action to limit the prices of prescription drugs could stifle innovation and lead to fewer medicines, she doesn’t sound convinced.


“I don’t deny anybody making a little money or having a successful business, but when you read about these pharmaceutical companies having billions and billions of dollars in profits — where’s it going?” Biter, 52, who lives in the Dallas area, told STAT in an interview. “Are they just greedy?”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!